体重管理

Search documents
谨防疯狂的减肥训练营趁热添乱
Bei Jing Qing Nian Bao· 2025-04-22 01:22
体重管理的形势大好、未来可期,但要谨防减肥训练营趁热添乱。"体重管理年"的推进,体现了社 会对全民健康的重视,但体重管理的发展需要通过规则和监管来护航。唯有将野蛮生长的减肥训练营纳 入监管的重点名单,通过体重管理门诊的优质服务满足民众的需求,才能避免减肥训练营趁热添乱,危 害民众健康。 治理减肥训练营乱象,首先要完善行业标准,明确训练营的场地、教练资质、急救配置等硬性要 求,设立准入门槛。此外,应加强合同监管,禁止"最终解释权归机构"等霸王条款。在日常监管方面, 要开展跨部门联合执法,对虚假宣传、安全隐患等突出问题重拳整治。还需通过宣传引导,让公众理性 看待减肥,认清快速减肥背后的风险,从需求端压缩类似减肥训练营的生存空间。 尤其对家长来说,控制孩子的体重,不一定要把孩子送去减肥训练营。家长和学校都要重视学生的 健康饮食,培养学生的健康饮食习惯,还要让孩子养成体育锻炼的良好习惯,提高孩子的身体素质,补 上体育教育的短板。同时还要大力推广全民健身运动,加快公共体育场馆建设,推进公共体育场馆对外 开放,为孩子营造良好的体育成长环境。 减肥训练营成了魔鬼训练营:拉伤发烧都得坚持,住宿环境恶劣饭少难吃。随着"体重管理 ...
中日友好医院多科室医生奉上权威减重攻略,揪出“隐形的胖子”
Xin Jing Bao· 2025-04-07 05:51
Core Insights - The article emphasizes the urgent need for weight management in China, highlighting that if not effectively addressed, the obesity rates among adults and children could reach 70.5% and 31.8% respectively by 2030 [1] Group 1: Obesity and Health Risks - Obesity is defined as excessive fat accumulation that negatively impacts health, with a Body Mass Index (BMI) over 28 indicating obesity [2] - Central obesity, indicated by waist circumference (≥90 cm for men and ≥85 cm for women), is more closely associated with metabolic disorders and health risks than BMI alone [2][5] - Obesity can lead to various diseases, including metabolic disorders, cardiovascular diseases, and psychological issues, necessitating a comprehensive approach to weight management [3] Group 2: Weight Management Strategies - A systematic assessment is recommended for obesity patients, including investigations into causes, physical examinations, and screening for related diseases [3] - Patients should receive guidance on nutrition, exercise, and psychological support as part of their weight management plan [3] - The target for weight loss is individualized, with a recommendation of a 5%-15% reduction in weight over 3-6 months, followed by maintenance [3] Group 3: Assessment Methods - The most common method for assessing obesity is BMI, with a normal range of 18.5-23.9, overweight at 24-27.9, and obesity at 28 or above [4] - Waist circumference and waist-to-hip ratio are also important metrics for assessing central obesity, which poses greater health risks [5] - Advanced methods like body composition analysis and imaging techniques can provide more precise assessments of fat distribution [6] Group 4: Lifestyle and Behavioral Changes - For individuals who are overweight but not obese, a combination of aerobic and resistance training is recommended, with a focus on moderate-intensity activities [7] - Daily physical activity, such as walking 8000-10000 steps, should be integrated into routines, along with resistance training [7] - Effective weight management requires lifestyle adjustments, including dietary changes and improved sleep quality, to regulate appetite and metabolism [10][11]
千亿市场群雄逐鹿,GLP-1领头雁华东医药司美格鲁肽国内上市申请获受理
Quan Jing Wang· 2025-04-01 09:42
Core Insights - Huadong Medicine's subsidiary, Jiangdong Company, received acceptance for the marketing application of Semaglutide injection for blood sugar control in adults with type 2 diabetes [1] - The clinical trial application for Semaglutide's weight management indication was approved in September 2024, with the Phase III trial completed in December 2024 [1] - Semaglutide is recognized for its significant market potential due to its effective blood sugar and weight management capabilities [2] Industry Overview - The global diabetes market is experiencing substantial growth, with the number of adults with diabetes increasing from approximately 200 million in 1990 to 828 million in 2022 [4] - In China, the number of adult diabetes patients reached about 148 million in 2022, accounting for 18% of the global total, with a high untreated rate of 52.7% [4] - The diabetes treatment market is expected to grow as clinical diagnosis and treatment rates improve [4] Company Developments - Huadong Medicine has a comprehensive pipeline of over 20 commercialized and in-development products targeting various diabetes treatment mechanisms, including GLP-1 receptor agonists [5] - The company’s Semaglutide injection demonstrated comparable efficacy and safety to Novo Nordisk's control drug in Phase III trials, with slightly lower adverse event rates [3] - Huadong Medicine is advancing multiple innovative products, including oral small molecule GLP-1 receptor agonists and dual-target agonists, with ongoing clinical trials [6][7] Market Position - Huadong Medicine is positioned as a strong competitor in the diabetes treatment sector, leveraging its extensive GLP-1 product pipeline and research capabilities [7] - The company aims to become a leading player in the GLP-1 market, capitalizing on its comprehensive product offerings and competitive advantages [7]
Keep的亏损,在意料之中
虎嗅APP· 2025-03-30 12:55
Core Viewpoint - The article emphasizes the increasing national focus on health and weight management, highlighting the potential for companies like Keep to leverage AI technology to reshape their business models and drive growth in the fitness industry [1][2][19]. Group 1: National Health Initiatives - The National Health Commission and 16 other departments have launched the "Weight Management Year" initiative to promote healthy lifestyles and chronic disease prevention [1]. - Weight management has become a hot topic during the recent National People's Congress, indicating a growing societal emphasis on health [1][2]. Group 2: Keep's Market Position - Keep has recently gained significant market attention, particularly after its founder's internal memo advocating for an all-in approach to AI, which led to a 48% stock price increase over two weeks [4]. - Despite reporting an expanded adjusted net loss, Keep aims to achieve breakeven by 2025, indicating a strategic pivot towards AI applications and wearable fitness devices [4][12]. Group 3: AI and Industry Transformation - The AI sector is experiencing a critical turning point, with major companies like Alibaba and Tencent significantly increasing their investments in AI and cloud infrastructure [6]. - The market is witnessing a shift in valuation logic, with AI expected to become a foundational element in various industries, including e-commerce and fitness [6][7]. Group 4: Importance of Application Scenarios - The article highlights that as AI technology matures, the focus will shift from technology itself to its application in real-world scenarios, which is crucial for companies to succeed [8][9]. - Companies with established user bases and data, such as Meitu and Duolingo, are successfully integrating AI to enhance user experience and drive revenue growth [9][10]. Group 5: Keep's Strategic Focus on AI - Keep's recent financial report shows a revenue of 2.066 billion RMB for the fiscal year ending December 31, 2024, with a gross profit margin increase from 45% to 46.7% [12]. - The company has a long history of investing in AI, dating back to 2018, and is now positioned to capitalize on the AI trend in the fitness sector [16][22]. Group 6: Challenges and Opportunities - The integration of AI in fitness presents both significant value and challenges, as the industry traditionally views exercise as a non-essential activity [17][20]. - The rising obesity rates in China, with 34.3% of adults classified as overweight and 16.4% as obese, underscore the growing demand for fitness solutions [19]. Group 7: Future Prospects - The potential for AI to enhance personalized fitness experiences could transform Keep's business model, shifting from content sales to personalized coaching services [22][24]. - Keep's accumulated expertise in understanding user needs and fitness dynamics positions it well to leverage AI for future growth [21][23].
中国减肥风暴
投资界· 2025-03-30 08:27
4亿人超重肥胖。 作者 | 何驰 编辑 | L 以下文章来源于新周刊 ,作者何驰 新周刊 . 中国最新锐的生活方式周刊。 来源 | 新周刊 (ID:new-weekly) 每次,当老王回家瘫倒在沙发上时,一座圆形的山丘便耸立在沙发中央,那不是别的什 么东西,而是老王的将军肚。 将军肚里囤积着茅台、拉菲、哈啤、大窑橙汁、鸭屎香单丛茶、兰州羊肉串、洞庭鱼头 王、尖叫牛蛙、双井卤煮,以及一堆精美的PPT商业提案和与客户称兄道弟、真真假假 的承诺。 作 为 一 名 营 销 高 管 , 年 近 四 旬 的 老 王 每 年 肩 负 着 要 为 公 司 拉 来 上 千 万 元 广 告 投 放 的 重 任,他的身体为此在北京的酒桌上拼尽了全力,代价是182斤的体重以及一个可以给女 儿当靠枕的将军肚,还有随之而来的胸闷气短和痛风。 最胖省份是河北, 最瘦省份是海南 这些年,中国人站起来了,中国人富起来了,中国人也胖起来了。 如果按体重指数(BMI)算,体重(公斤)除以身高(米)的平方,得数介于18.5~24 之间为正常,超过24为超重,超过28即为肥胖。其他肥胖评价指数还包括腰围、腰臀 比、内脏脂肪等。 医生们有句行话,叫"裤 ...
升级营养餐、关注心理问题 “小胖墩”合理减重专家支招
Yang Shi Xin Wen Ke Hu Duan· 2025-03-30 07:38
0:00 眼下,体重管理成为公众热议的话题。近日,大连理工大学专门开设了体重管理特色课,帮助学生们科学减脂。 大连理工大学体育与健康学院院长 李芃松:结合学生的身体条件,配合"一秤一尺一日历"的管理,开展陆上训练和水中训练,学生每次课的热量消耗计划 是达到600到800千卡。 在健康饮食课程中,学校特地设置了健康餐窗口,为学生们提供种类丰富、价格合理、营养均衡的热量管理餐食。 学校推出的体重管理特色课,由科学锻炼、健康饮食和心理疏导三个方面的不同课程组成。课程虽然为选修课,但由专业体育老师进行指导,带领大家进行 有氧、燃脂等不同类型的运动训练,十分受欢迎。3月25日以来,已经有近20名学生报名参与。 大连理工大学建筑与艺术学院学生 苏春木:老师做了一些非常非常专业的指导,我也是希望把自己的体重成功减下来。 大连理工大学建筑与艺术学院学生 魏万鹏:我觉得学校新开设的这门选修课挺棒的,运动课程环节我很喜欢。老师带着我们做这种体能训练,以后还有各 类运动器材和游泳,课程内容很丰富。 据了解,这项特色选修课程分为21天的短期班和一个学期的长期班两种形式,学生们可根据自身情况进行选择。学生们上课前,首先需要完成包括血压 ...
糖酒会吹“减糖”风 “体重管理”助力健康经济
Zhong Guo Xin Wen Wang· 2025-03-25 11:36
糖酒会吹"减糖"风 "体重管理"助力健康经济 中新社成都3月25日电 (记者 贺劭清)慢碳水臭豆腐荞麦面、能抑制蔗糖吸收的姜红糖、便携五谷杂粮养 生粥……25日在成都开幕的第112届全国糖酒商品交易会(下称"糖酒会")首设健康食品及科技服务专 区,多种有助于"体重管理"的低GI(低血糖生成指数)食品集中展出。 3月25日, 第112届全国糖酒商品交易会在成都开幕。图为采购商、消费者选购健康食品。 中新社记者 贺劭清 摄 在糖酒会"低卡博士"展台,研发人员刘俊正针对来往客商进行荞麦面口味的调研。在刘俊看来,对于消 费者而言,健康饮食不仅有助于身体健康,还能提供一定情绪价值。商家需根据市场风向加快研发力 度,营造消费新场景。 除了食品新势力,不少中华老字号也加入减糖大军。"三年前我们就观察到了健康饮食在中国的快速发 展,但转型需要过程。"中国全聚德集团总经理周延龙介绍,从年夜饭到中秋节月饼,今年全聚德的大 部分产品都进行了减糖、减脂。 早在2024年6月,中国国家卫生健康委等16个部门就联合印发《"体重管理年"活动实施方案》。今年全 国两会期间,国家卫健委主任雷海潮在民生主题记者会上用7分钟讲体重管理,"体重管理 ...
乘着“体重管理年”的东风,茶马汇茶业焕新“茶与健康”
Sou Hu Wang· 2025-03-24 07:05
乘着"体重管理年"的东风,茶马汇茶业焕新"茶与健 康" 国家卫健委发布了《2025年全民健康体重管理行动计划》,"明确将体重管理作为年度重点健康工作之 一,通过政策引导、健康教育、社区支持等多方面措施,帮助民众实现科学减重,预防肥胖相关疾 病"。 国家实施"体重管理年"3年行动,掀起"国家出手整治居民体重"全民讨论热潮,健康生活方式成为主 流。茶与健康有着天然紧密联系,茶业、体育用品、健身行业等迎来了拓宽受众、发扬文化的新机遇。 茶为何健康 据中国工程院院士、中国农科院茶叶研究所研究员陈宗懋表示:"茶不是药,但饮茶可以预防和减轻人 体疾病,可以作为调节剂,增强体质,提高抗病性";浙江大学茶学系教授屠幼英则表示:"乌龙茶里面 含有比较多的咖啡因和茶多酚,咖啡因具有燃烧脂肪的作用,茶多酚具有抑制脂肪吸收的效果"。武夷 岩茶是乌龙茶的杰出代表,武夷山的乌龙茶,统称武夷岩茶,正如茶马汇的每款茶都有自己的特点。茶 与健康源远流长,《神农本草经》有记载,"神农尝百草,日遇七十二毒,得茶而解之"。 在国际上,美国食品药品监督管理局(FDA)"将茶及茶饮品纳入可标准'健康声明'的食品范围"新规4月28 日将生效。国际茶叶委员 ...
达能全球CEO谈“体重管理”:关注生命早期喂养方式
Zhong Guo Xin Wen Wang· 2025-03-24 06:19
达能全球CEO谈"体重管理":关注生命早期喂养方 式 中新网北京3月24日电 (记者 夏宾)在中国发展高层论坛2025年年会期间,达能全球首席执行官盛睿 安(Antoine de Saint-Affrique)对中新网记者表示,生命早期的喂养方式与肥胖、非传染性疾病之间密切 相关,而日常膳食在守护健康中发挥着关键作用。 谈及中国市场,盛睿安表示,中国正引领全球创新前沿。对达能而言,中国不仅是重要的市场,更 代表着全球顶尖的创新生态。我们在中国培养的优秀人才团队,既服务于本土市场,也推动着全球业务 发展。我们在中国已经设立了开放科研中心和实验室,未来还将再建一个。中国不仅是创新高地,更是 人才汇聚之地,拥有全球顶尖的人才储备,涵盖了科学研究、人工智能和商业领域的各类精英。 "我们在本次论坛上深入探讨了生物科技与人工智能领域的创新实践。中国拥有庞大的市场规模, 居民财富持续积累,消费潜力的不断释放将成为中国高质量发展的重大机遇。"盛睿安说。 盛睿安表示,这些努力不仅是为了应对当前的公共卫生挑战,更是对全球范围内营养理念深刻转变 的一种响应。他指出,"越来越多的国家从'吃得饱'迈向'吃得好、吃得健康',中国也不例外 ...
医药生物行业周报(3月第2周):国家卫健委将持续推进体重管理
Century Securities· 2025-03-17 00:48
Investment Rating - The report does not explicitly state an investment rating for the industry [2] Core Insights - The pharmaceutical and biotechnology sector saw a weekly increase of 1.77%, outperforming the Wind All A index (1.49%) and the CSI 300 index (1.59%) [3][8] - Offline pharmacies and pharmaceutical distribution significantly outperformed the index with increases of 10.38% and 4.91% respectively, while in vitro diagnostics (0.77%), raw materials (0.83%), and other biological products (0.89%) lagged behind [3][9] - The report highlights the ongoing "Weight Management Year" initiative launched by the National Health Commission, emphasizing the need for continuous efforts in managing obesity and related chronic diseases [3][12] - The introduction of a pricing guide for brain-computer interface services by the National Medical Insurance Administration aims to accelerate the clinical application of new technologies [3][12] Market Weekly Review - The pharmaceutical and biotechnology sector increased by 1.77%, outperforming the Wind All A index (1.49%) and the CSI 300 index (1.59%) [3][8] - Key performers included offline pharmacies (10.38%) and pharmaceutical distribution (4.91%), while in vitro diagnostics (0.77%) and raw materials (0.83%) underperformed [3][9] - Top gainers included Kingmed Diagnostics (42.43%), Sanyou Medical (34.47%), and Dongfang Ocean (25%), while the largest declines were seen in Shuangcheng Pharmaceutical (-16.56%), Haichuang Pharmaceutical-U (-12.21%), and Ailis (-11.09%) [3][10] Industry News and Key Company Announcements - The National Health Commission's initiative on weight management aims to address obesity and its associated health risks, with a focus on chronic disease prevention [3][12] - The National Medical Insurance Administration has established pricing for brain-computer interface services, facilitating the transition of innovative technologies to clinical use [3][12] - Roche announced a collaboration with Zealand Pharma to develop a long-acting insulin analog, with a total transaction value of $5.3 billion [3][12] - Clinical trials for various drugs, including those for obesity and hypertension, have shown promising results, indicating potential market opportunities [3][14][16][18]